The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Regenerative Therapies for Osteoarthritis-Global Market Insights and Sales Trends 2024
Synopsis
Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.
The global Regenerative Therapies for Osteoarthritis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Therapies for Osteoarthritis in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Orthopaedic Clinics and Research Institutes, are propelling Regenerative Therapies for Osteoarthritis market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Engineering segment is estimated at % CAGR for the next seven-year period.
The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Regenerative Therapies for Osteoarthritis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Regenerative Therapies for Osteoarthritis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Regenerative Therapies for Osteoarthritis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Regenerative Therapies for Osteoarthritis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Regenerative Therapies for Osteoarthritis covered in this report include Acelity, Mesoblast, Nuo Therapeutics, Astellas Pharma, Organovo, Orgenesis, Sanofi, Athersys and Takeda, etc.
The global Regenerative Therapies for Osteoarthritis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acelity
Mesoblast
Nuo Therapeutics
Astellas Pharma
Organovo
Orgenesis
Sanofi
Athersys
Takeda
Cytori Therapeutics
Global Regenerative Therapies for Osteoarthritis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Regenerative Therapies for Osteoarthritis market, Segment by Type:
Cell Therapy
Tissue Engineering
Gene Therapy
Global Regenerative Therapies for Osteoarthritis market, by Application
Hospitals
Ambulatory Surgical Centers
Orthopaedic Clinics
Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Regenerative Therapies for Osteoarthritis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.
The global Regenerative Therapies for Osteoarthritis market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Therapies for Osteoarthritis in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Orthopaedic Clinics and Research Institutes, are propelling Regenerative Therapies for Osteoarthritis market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Tissue Engineering segment is estimated at % CAGR for the next seven-year period.
The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Regenerative Therapies for Osteoarthritis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Regenerative Therapies for Osteoarthritis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Regenerative Therapies for Osteoarthritis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Regenerative Therapies for Osteoarthritis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Regenerative Therapies for Osteoarthritis covered in this report include Acelity, Mesoblast, Nuo Therapeutics, Astellas Pharma, Organovo, Orgenesis, Sanofi, Athersys and Takeda, etc.
The global Regenerative Therapies for Osteoarthritis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Acelity
Mesoblast
Nuo Therapeutics
Astellas Pharma
Organovo
Orgenesis
Sanofi
Athersys
Takeda
Cytori Therapeutics
Global Regenerative Therapies for Osteoarthritis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Regenerative Therapies for Osteoarthritis market, Segment by Type:
Cell Therapy
Tissue Engineering
Gene Therapy
Global Regenerative Therapies for Osteoarthritis market, by Application
Hospitals
Ambulatory Surgical Centers
Orthopaedic Clinics
Research Institutes
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Regenerative Therapies for Osteoarthritis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Regenerative Therapies for Osteoarthritis
1.1 Regenerative Therapies for Osteoarthritis Market Overview
1.1.1 Regenerative Therapies for Osteoarthritis Product Scope
1.1.2 Regenerative Therapies for Osteoarthritis Market Status and Outlook
1.2 Global Regenerative Therapies for Osteoarthritis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Regenerative Therapies for Osteoarthritis Market Size by Region (2018-2029)
1.4 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Region (2018-2023)
1.5 Global Regenerative Therapies for Osteoarthritis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Regenerative Therapies for Osteoarthritis Market Size (2018-2029)
1.6.1 North America Regenerative Therapies for Osteoarthritis Market Size (2018-2029)
1.6.2 Europe Regenerative Therapies for Osteoarthritis Market Size (2018-2029)
1.6.3 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size (2018-2029)
1.6.4 Latin America Regenerative Therapies for Osteoarthritis Market Size (2018-2029)
1.6.5 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size (2018-2029)
2 Regenerative Therapies for Osteoarthritis Market by Type
2.1 Introduction
2.1.1 Cell Therapy
2.1.2 Tissue Engineering
2.1.3 Gene Therapy
2.2 Global Regenerative Therapies for Osteoarthritis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Type (2018-2023)
2.2.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Regenerative Therapies for Osteoarthritis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Regenerative Therapies for Osteoarthritis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Regenerative Therapies for Osteoarthritis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Breakdown by Type (2018-2029)
3 Regenerative Therapies for Osteoarthritis Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Orthopaedic Clinics
3.1.4 Research Institutes
3.2 Global Regenerative Therapies for Osteoarthritis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Application (2018-2023)
3.2.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Regenerative Therapies for Osteoarthritis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Regenerative Therapies for Osteoarthritis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Regenerative Therapies for Osteoarthritis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Regenerative Therapies for Osteoarthritis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Regenerative Therapies for Osteoarthritis Revenue Breakdown by Application (2018-2029)
4 Regenerative Therapies for Osteoarthritis Competition Analysis by Players
4.1 Global Regenerative Therapies for Osteoarthritis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2022)
4.3 Date of Key Players Enter into Regenerative Therapies for Osteoarthritis Market
4.4 Global Top Players Regenerative Therapies for Osteoarthritis Headquarters and Area Served
4.5 Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service
4.6 Competitive Status
4.6.1 Regenerative Therapies for Osteoarthritis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Acelity
5.1.1 Acelity Profile
5.1.2 Acelity Main Business
5.1.3 Acelity Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.1.4 Acelity Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.1.5 Acelity Recent Developments
5.2 Mesoblast
5.2.1 Mesoblast Profile
5.2.2 Mesoblast Main Business
5.2.3 Mesoblast Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.2.4 Mesoblast Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.2.5 Mesoblast Recent Developments
5.3 Nuo Therapeutics
5.3.1 Nuo Therapeutics Profile
5.3.2 Nuo Therapeutics Main Business
5.3.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.3.4 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.3.5 Astellas Pharma Recent Developments
5.4 Astellas Pharma
5.4.1 Astellas Pharma Profile
5.4.2 Astellas Pharma Main Business
5.4.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.4.4 Astellas Pharma Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.4.5 Astellas Pharma Recent Developments
5.5 Organovo
5.5.1 Organovo Profile
5.5.2 Organovo Main Business
5.5.3 Organovo Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.5.4 Organovo Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.5.5 Organovo Recent Developments
5.6 Orgenesis
5.6.1 Orgenesis Profile
5.6.2 Orgenesis Main Business
5.6.3 Orgenesis Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.6.4 Orgenesis Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.6.5 Orgenesis Recent Developments
5.7 Sanofi
5.7.1 Sanofi Profile
5.7.2 Sanofi Main Business
5.7.3 Sanofi Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.7.4 Sanofi Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.7.5 Sanofi Recent Developments
5.8 Athersys
5.8.1 Athersys Profile
5.8.2 Athersys Main Business
5.8.3 Athersys Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.8.4 Athersys Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.8.5 Athersys Recent Developments
5.9 Takeda
5.9.1 Takeda Profile
5.9.2 Takeda Main Business
5.9.3 Takeda Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.9.4 Takeda Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.9.5 Takeda Recent Developments
5.10 Cytori Therapeutics
5.10.1 Cytori Therapeutics Profile
5.10.2 Cytori Therapeutics Main Business
5.10.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Products, Services and Solutions
5.10.4 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Revenue (US$ Million) & (2018-2023)
5.10.5 Cytori Therapeutics Recent Developments
6 North America
6.1 North America Regenerative Therapies for Osteoarthritis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Therapies for Osteoarthritis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Therapies for Osteoarthritis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Regenerative Therapies for Osteoarthritis Market Dynamics
11.1 Regenerative Therapies for Osteoarthritis Industry Trends
11.2 Regenerative Therapies for Osteoarthritis Market Drivers
11.3 Regenerative Therapies for Osteoarthritis Market Challenges
11.4 Regenerative Therapies for Osteoarthritis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
